Canton, MA, United States of America

Mark Tepper


 

 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 29(Granted Patents)


Location History:

  • Canton, MA (US) (2002 - 2010)
  • Norwood, MA (US) (2017 - 2018)
  • Newton, MA (US) (2010 - 2021)

Company Filing History:


Years Active: 2002-2021

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: The Innovative Contributions of Mark Tepper in Medicinal Chemistry

Introduction: Mark Tepper, a notable inventor based in Canton, MA, has made significant strides in the field of medicinal chemistry. With a total of 14 patents to his name, Tepper's work focuses on breakthroughs that have the potential to advance treatments for various diseases and conditions.

Latest Patents: Among Tepper's latest innovations is his patent for ultrapure tetrahydrocannabinol-11-oic acids. This application pertains to ultrapure ajulemic acid, emphasizing its synthesis, pharmaceutical compositions, and various methods of use. His work targets the treatment and prevention of inflammation, pain, and fibrotic diseases, including conditions like scleroderma, systemic sclerosis, and liver cirrhosis, among others. This patented research could revolutionize the medical approach to managing and alleviating symptoms related to these serious health issues.

Career Highlights: Mark Tepper has contributed to the advancement of medicinal chemistry throughout his career. He has been affiliated with notable companies such as Corbus Pharmaceuticals, Inc. and Applied Research Systems Ars Holding N.V. These positions have enabled him to collaborate with other experts and refine his innovations, leading to impactful patents and research advancements.

Collaborations: Throughout his career, Tepper has collaborated with esteemed colleagues, including Sean D. McKenna and Stephen S. Palmer. These partnerships have facilitated knowledge sharing and innovation, ultimately enhancing the development of his patented technologies.

Conclusion: With a robust portfolio of 14 patents and impactful collaborations, Mark Tepper stands out as an influential inventor within medicinal chemistry. His focus on ultrapure tetrahydrocannabinol-11-oic acids not only showcases his commitment to innovation but also holds promise for improving treatment options for various serious medical conditions. As his research continues, the contributions of Mark Tepper to the field will likely pave the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…